secwatch.observer — SEC 8-K summary
======================================

Issuer:     ProPhase Labs, Inc. (PRPH)
CIK:        0000868278
Form:       8-K
Filed at:   2025-07-01T23:59:59+00:00
Accession:  0001641172-25-017286
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

ProPhase Labs regains Nasdaq compliance after appointing new independent director
--------------------------------------------------------------------------------

- Appointed Carolina Abenante as independent director on June 20, 2025.
- Abenante will join the Audit Committee effective July 19, 2025, the day after the annual meeting.
- Nasdaq confirmed compliance with Listing Rule 5605(c)(2) on June 25, 2025, closing the matter.
- Non-compliance stemmed from Eleanor McBrier's resignation in September 2024, causing an audit committee vacancy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/868278/000164117225017286/0001641172-25-017286-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/868278/000164117225017286/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-017286

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer